Since 2018, BioPortUSA has had the pleasure of working with an number of different international life science companies on both the medical device and pharmaceutical side of things. The following are some of the companies we have worked with:
Alcyomics provides novel solutions for pre-clinical drug safety and efficacy testing of therapeutics including cellular therapies which is also extended to the chemical and cosmetic industries. Alcyomics takes the lead in providing unique screening services using human in vitro skin explant assays enabling more cost effective commercialisation of products and or drugs.
The Alcyomics development pipeline includes drug discovery disease modelling for the identification of novel drug targets.
BacTrace develops portable integrated systems that allow test results within minutes on site, rather than from a laboratory within days or even weeks. The small size, highly sensitive and validated systems perfectly serve the needs in clinical point-of-care settings to help making fast triage and treatment decisions, as well as in environmental applications, such as water contamination assessment.
Cerebriu improves workflow efficiency, quality and patient outcomes in diagnostic imaging. Our software solution Cerebriu Apollo achieves this by automating image acquisition protocols and triage during MRI brain acquisition providing decision support at key stages of the diagnostic process. Ultimately this results in improved productivity, prioritizing the right patients at the right time and less stress for clinicians.
Providing critical personal protective equipment to the healthcare industry, Detmold Medical promotes high quality products. Detmold Medical is a part of the Detmold Group, a leading manufacturer of paper and board based sustainable packaging products for a diverse customer base across both the foodservice and retail industry.
Digid is developing a breakthrough digital diagnostics platform built upon its proprietary nanotech CantisenseTM biosensor technology and an ecosystem of mobile applications to enable real-time, A.I-powered diagnostics of human and animal biodata.
Based in Strasbourg, Fizimed is specialized in developing innovative connected medical devices. The multidisciplinary team has won many contests and the Emy connected trainer for pelvic floor re-education is its first medical device.
Fast and Reliable Results in Cancer Diagnostics. Oncgnostics designs in-vitro diagnostic tests for the detection of DNA methylation, which is associated with a wide variety of cancers. The company uses reliable epigenetic biomarkers to create products such as GynTect®, which is a clarification test for cervical cancer and its precursors. Results are rapid, allowing clinicians to detect cancers in early stages of development. Oncgnostics implements an ISO: 13485 certified quality management system in its research, development and manufacturing processes.
Optomed Plc is a Finnish health care technology company and one of the leading providers of handheld fundus cameras and eye-screening solutions. Optomed combines cameras with software and AI to revolutionise the diagnostic process of blinding diseases such as rapidly-increasing diabetic retinopathy. Optomed’s customers consist of international health care organisations, hospitals, and leading global medical technology companies and distributors.
Protection Impuls is an idea born out of a midwife’s need that has quickly evolved into a global supplier of personal protection equipment (PPE). Their goal: Protect as many lives worldwide as possible by providing a certified, secure, globally scalable and affordable face shield.
Teicos Pharma Oy aims to become the leading provider of manufacturing solutions for carrier-free inhalable API powders used in dry powder inhalers. We strive to be the preferred partner of pharmaceutical companies acting in the field of inhalation therapy. Their strategy is to develop, licence and sell customer specific dry powder formulations and reformulations of drug molecules for use in local or systemicinhalation therapy.
Established in 2007, Teicos Pharma is a spin-off from the Helsinki University of Technology (now Aalto University), Finland. Founding partners include four leading senior scientists from materials, characterization and aerosol technologies originating from Finland and the USA.
Thornhill Medical was spun off from the University Health Network, Toronto, Canada, in 2004 to commercialize the ideas and research of Drs. Joe Fisher and Ludwik Fedorko, Steve Iscoe, Jim Duffin and a group of founding engineers. Today, Thornhill Medical’s innovative medical technology is changing the global face of emergency medicine for first responders and the military.